Endurant Capital Management LP - Q4 2016 holdings

$242 Million is the total value of Endurant Capital Management LP's 73 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 53.1% .

 Value Shares↓ Weighting
SHPG SellSHIRE PLCsponsored adr$16,041,000
-13.4%
94,146
-1.5%
6.63%
-3.4%
HLS SellHEALTHSOUTH CORP$9,873,000
+0.3%
239,404
-1.4%
4.08%
+11.8%
STJ BuyST JUDE MED INC$9,685,000
+11.3%
120,777
+10.8%
4.00%
+24.1%
ABT SellABBOTT LABS$8,928,000
-14.4%
232,449
-5.7%
3.69%
-4.6%
UNH SellUNITEDHEALTH GROUP INC$8,507,000
+2.9%
53,156
-10.0%
3.52%
+14.7%
HOLX SellHOLOGIC INC$8,022,000
-7.2%
199,958
-10.2%
3.32%
+3.5%
BDX BuyBECTON DICKINSON & CO$7,781,000
+2181.8%
47,000
+2373.7%
3.22%
+2451.6%
AGN SellALLERGAN PLC$7,711,000
-44.9%
36,716
-39.6%
3.19%
-38.6%
BSX BuyBOSTON SCIENTIFIC CORP$7,185,000
+16.9%
332,198
+28.6%
2.97%
+30.3%
SYK SellSTRYKER CORP$7,047,000
-15.5%
58,815
-17.9%
2.91%
-5.8%
WBA SellWALGREENS BOOTS ALLIANCE INC$6,618,000
-14.9%
79,964
-17.1%
2.74%
-5.1%
ESRX BuyEXPRESS SCRIPTS HLDG CO$6,613,000
+22.0%
96,127
+25.1%
2.73%
+36.0%
ABC BuyAMERISOURCEBERGEN CORP$6,532,000
+15.6%
83,540
+19.4%
2.70%
+28.8%
HRC BuyHILL ROM HLDGS INC$6,250,000
+425.2%
111,335
+479.9%
2.58%
+485.7%
MCK SellMCKESSON CORP$6,078,000
-21.2%
43,272
-6.5%
2.51%
-12.2%
BCR BuyBARD C R INC$5,533,000
+55.9%
24,627
+55.6%
2.29%
+73.7%
DVA BuyDAVITA INC$5,395,000
+2.9%
84,039
+5.9%
2.23%
+14.7%
WMGI BuyWRIGHT MED GROUP N V$5,280,000
+13.5%
229,777
+21.2%
2.18%
+26.6%
AET SellAETNA INC NEW$5,189,000
-46.3%
41,843
-50.0%
2.14%
-40.1%
TMO BuyTHERMO FISHER SCIENTIFIC INC$5,148,000
+56.5%
36,486
+76.4%
2.13%
+74.5%
MNKKQ SellMALLINCKRODT PUB LTD CO$4,939,000
-41.3%
99,128
-17.9%
2.04%
-34.6%
PFE NewPFIZER INC$4,518,000139,100
+100.0%
1.87%
CELG BuyCELGENE CORP$4,107,000
+17.3%
35,480
+6.0%
1.70%
+30.8%
ANTM BuyANTHEM INC$4,040,000
+311.8%
28,100
+258.9%
1.67%
+358.5%
CVS BuyCVS HEALTH CORP$3,669,000
+38.9%
46,500
+56.7%
1.52%
+54.9%
CNC SellCENTENE CORP DEL$3,598,000
-40.7%
63,676
-29.8%
1.49%
-33.9%
EVHC NewENVISION HEALTHCARE CORP$3,538,00055,900
+100.0%
1.46%
CAH BuyCARDINAL HEALTH INC$3,534,000
+399.9%
49,100
+439.6%
1.46%
+457.3%
GSK NewGLAXOSMITHKLINE PLCsponsored adr$3,327,00086,400
+100.0%
1.38%
HSIC NewSCHEIN HENRY INC$3,216,00021,200
+100.0%
1.33%
PEN BuyPENUMBRA INC$3,158,000
+477.3%
49,500
+587.5%
1.30%
+542.9%
CI SellCIGNA CORPORATION$3,088,000
-15.2%
23,150
-17.2%
1.28%
-5.5%
LLY NewLILLY ELI & CO$2,802,00038,100
+100.0%
1.16%
HCA SellHCA HOLDINGS INC$2,746,000
-36.7%
37,100
-35.4%
1.14%
-29.5%
BIIB SellBIOGEN INC$2,703,000
-50.5%
9,532
-45.3%
1.12%
-44.8%
BBH BuyVANECK VECTORS ETF TRbiotech etf$2,652,000
+274.0%
24,650
+300.8%
1.10%
+316.7%
MYL SellMYLAN N V$2,526,000
-27.2%
66,200
-27.2%
1.04%
-18.8%
AERI BuyAERIE PHARMACEUTICALS INC$2,371,000
+49.5%
62,630
+49.0%
0.98%
+66.7%
AKRXQ SellAKORN INC$2,312,000
-25.7%
105,900
-7.2%
0.96%
-17.2%
ZBH SellZIMMER BIOMET HLDGS INC$2,205,000
-47.3%
21,364
-33.7%
0.91%
-41.3%
NewFLUIDIGM CORP DELnote 2.750% 2/0$2,183,0003,161,000
+100.0%
0.90%
INCY BuyINCYTE CORP$2,025,000
+329.9%
20,200
+304.0%
0.84%
+378.3%
JAZZ NewJAZZ PHARMACEUTICALS PLC$1,788,00016,400
+100.0%
0.74%
CTLT BuyCATALENT INC$1,591,000
+33.8%
59,008
+28.3%
0.66%
+49.0%
ACHC NewACADIA HEALTHCARE COMPANY IN$1,483,00044,800
+100.0%
0.61%
CRL SellCHARLES RIV LABS INTL INC$1,409,000
-52.8%
18,488
-48.3%
0.58%
-47.4%
LH SellLABORATORY CORP AMER HLDGS$1,401,000
-65.1%
10,912
-62.6%
0.58%
-61.1%
FOLD BuyAMICUS THERAPEUTICS INC$1,120,000
+253.3%
225,300
+425.2%
0.46%
+295.7%
STE BuySTERIS PLC$1,119,000
+61.2%
16,600
+74.7%
0.46%
+79.8%
EW NewEDWARDS LIFESCIENCES CORP$993,00010,600
+100.0%
0.41%
JNJ SellJOHNSON & JOHNSON$968,000
-51.5%
8,400
-50.3%
0.40%
-45.9%
MDCO BuyMEDICINES CO$927,000
+19.3%
27,300
+32.5%
0.38%
+33.0%
EXEL BuyEXELIXIS INC$908,000
+41.2%
60,870
+21.0%
0.38%
+57.6%
TEVA SellTEVA PHARMACEUTICAL INDS LTDadr$868,000
-85.9%
23,933
-82.1%
0.36%
-84.2%
CLVS BuyCLOVIS ONCOLOGY INC$817,000
+173.2%
18,400
+121.7%
0.34%
+204.5%
PPH NewVANECK VECTORS ETF TRpharmaceutical e$819,00015,600
+100.0%
0.34%
REGN NewREGENERON PHARMACEUTICALS$808,0002,200
+100.0%
0.33%
DERM SellDERMIRA INC$761,000
-14.1%
25,088
-4.2%
0.31%
-4.3%
ONCE BuySPARK THERAPEUTICS INC$739,000
+112.4%
14,800
+155.2%
0.30%
+136.4%
ENDP SellENDO INTL PLC$728,000
-66.8%
44,196
-59.3%
0.30%
-62.9%
NVRO SellNEVRO CORP$684,000
-47.9%
9,420
-25.1%
0.28%
-41.9%
AMGN SellAMGEN INC$637,000
-51.4%
4,358
-44.5%
0.26%
-45.9%
OCRX BuyOCERA THERAPEUTICS INC$476,000
+75.0%
226,442
+119.5%
0.20%
+95.0%
NBIX SellNEUROCRINE BIOSCIENCES INC$445,000
-28.0%
11,500
-5.7%
0.18%
-19.7%
ARRY BuyARRAY BIOPHARMA INC$247,000
+263.2%
28,100
+181.0%
0.10%
+308.0%
OXFD SellOXFORD IMMUNOTEC GLOBAL PLC$240,000
-82.9%
16,056
-85.6%
0.10%
-81.0%
SPNC SellSPECTRANETICS CORP$236,000
-81.9%
9,626
-81.5%
0.10%
-79.8%
SRPT NewSAREPTA THERAPEUTICS INC$230,0008,400
+100.0%
0.10%
PARNF SellPARNELL PHARMACEUT HLDGS LTD$227,000
-64.4%
328,781
-26.7%
0.09%
-60.2%
DVAX NewDYNAVAX TECHNOLOGIES CORP$224,00056,800
+100.0%
0.09%
BAX SellBAXTER INTL INC$208,000
-47.5%
4,700
-43.4%
0.09%
-41.5%
RXDX SellIGNYTA INC$138,000
-57.9%
26,012
-50.2%
0.06%
-53.3%
GLYC NewGLYCOMIMETICS INC$88,00014,500
+100.0%
0.04%
RAD ExitRITE AID CORP$0-17,700
-100.0%
-0.05%
RGNX ExitREGENXBIO INC$0-12,026
-100.0%
-0.06%
CHRS ExitCOHERUS BIOSCIENCES INC$0-8,400
-100.0%
-0.08%
ANIP ExitANI PHARMACEUTICALS INC$0-4,600
-100.0%
-0.11%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-84,443
-100.0%
-0.12%
MRK ExitMERCK & CO INC$0-5,100
-100.0%
-0.12%
RDUS ExitRADIUS HEALTH INC$0-6,300
-100.0%
-0.13%
TSRO ExitTESARO INC$0-3,400
-100.0%
-0.13%
PCRX ExitPACIRA PHARMACEUTICALS INC$0-10,500
-100.0%
-0.13%
ExitTRILLIUM THERAPEUTICS INC$0-24,400
-100.0%
-0.13%
NLNK ExitNEWLINK GENETICS CORP$0-29,791
-100.0%
-0.17%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-5,150
-100.0%
-0.17%
HZNP ExitHORIZON PHARMA PLC$0-26,040
-100.0%
-0.18%
KITE ExitKITE PHARMA INC$0-9,800
-100.0%
-0.20%
VRX ExitVALEANT PHARMACEUTICALS INTL$0-22,400
-100.0%
-0.20%
KERX ExitKERYX BIOPHARMACEUTICALS INC$0-116,000
-100.0%
-0.23%
ILMN ExitILLUMINA INC$0-3,470
-100.0%
-0.23%
ALDR ExitALDER BIOPHARMACEUTICALS INC$0-19,500
-100.0%
-0.24%
NVLS ExitNIVALIS THERAPEUTICS INC$0-85,412
-100.0%
-0.26%
PRXL ExitPAREXEL INTL CORP$0-10,100
-100.0%
-0.26%
TNDM ExitTANDEM DIABETES CARE INC$0-94,812
-100.0%
-0.27%
CSLT ExitCASTLIGHT HEALTH INCcl b$0-184,826
-100.0%
-0.28%
UHS ExitUNIVERSAL HLTH SVCS INCcl b$0-6,657
-100.0%
-0.30%
GI ExitENDOCHOICE HLDGS INC$0-121,663
-100.0%
-0.36%
BKD ExitBROOKDALE SR LIVING INC$0-59,070
-100.0%
-0.38%
FVE ExitFIVE STAR QUALITY CARE INC$0-575,076
-100.0%
-0.41%
XRAY ExitDENTSPLY SIRONA INC$0-18,900
-100.0%
-0.42%
NSTG ExitNANOSTRING TECHNOLOGIES INC$0-69,574
-100.0%
-0.52%
PRGO ExitPERRIGO CO PLC$0-15,100
-100.0%
-0.52%
A ExitAGILENT TECHNOLOGIES INC$0-30,585
-100.0%
-0.53%
LHCG ExitLHC GROUP INC$0-42,700
-100.0%
-0.58%
CNMD ExitCONMED CORP$0-39,500
-100.0%
-0.59%
GILD ExitGILEAD SCIENCES INC$0-20,810
-100.0%
-0.61%
ExitFLUIDIGM CORP DELnote 2.750% 2/0$0-4,161,000
-100.0%
-0.93%
AMAG ExitAMAG PHARMACEUTICALS INC$0-114,980
-100.0%
-1.04%
VWR ExitVWR CORP$0-107,422
-100.0%
-1.13%
AMSG ExitAMSURG CORP$0-147,500
-100.0%
-3.67%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings